Rafferty Asset Management
IMNM icon

Rafferty Asset Management’s Immunome IMNM Stock Holding History

Rafferty Asset Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.42M Buy
156,220
+42,825
+38% +$953K 0.01% 494
2025
Q4 		$2.44M Buy
113,395
+26,905
+31% +$472K 0.01% 606
2025
Q3 		$1.01M Buy
86,490
+10,088
+13% +$100K ﹤0.01% 788
2025
Q2 		$711K Sell
76,402
-26,073
-25% -$214K ﹤0.01% 816
2025
Q1 		$690K Buy
102,475
+21,084
+26% +$202K ﹤0.01% 813
2024
Q4 		$864K Sell
81,391
-5,698
-7% -$68.9K ﹤0.01% 819
2024
Q3 		$1.27M Sell
87,089
-28,956
-25% -$411K ﹤0.01% 749
2024
Q2 		$1.4M Buy
+116,045
New +$1.82M 0.01% 739

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Rafferty Asset Management's IMNM Position: Q1 2026 in Review

Rafferty Asset Management increased its Immunome (IMNM) stake by 38% in Q1 2026, buying an estimated $953K and bringing the position to 156,220 shares worth $3.42M. The position accounts for 0.01% of the portfolio, ranked #494.

Rafferty Asset Management first reported a position in IMNM in Q2 2024 and has held it in 8 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Rafferty Asset Management held 156,220 shares of Immunome worth $3.42M as of Q1 2026.
  • Rafferty Asset Management bought 42,825 Immunome shares in Q1 2026, an estimated $953K.
  • Immunome made up 0.01% of Rafferty Asset Management's portfolio in Q1 2026, its #494 holding.
  • Rafferty Asset Management first reported a position in Immunome in Q2 2024 and has held it in 8 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.